Thomas Steyer’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,000
Closed -$269K 167
2026
Q1
$269K Hold
14,000
﹤0.01% 127
2025
Q4
$265K Hold
14,000
﹤0.01% 116
2025
Q3
$261K Hold
14,000
﹤0.01% 109
2025
Q2
$258K Hold
14,000
﹤0.01% 111
2025
Q1
$245K Hold
14,000
﹤0.01% 114
2024
Q4
$242K Hold
14,000
﹤0.01% 120
2024
Q3
$261K Hold
14,000
﹤0.01% 124
2024
Q2
$216K Hold
14,000
﹤0.01% 133
2024
Q1
$207K Hold
14,000
﹤0.01% 147
2023
Q4
$200K Buy
+14,000
New +$199K ﹤0.01% 132

Other funds holding SBRA

Thomas Steyer's SBRA Position: Q2 2026 in Review

Thomas Steyer sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 14,000 shares — an estimated $269K sold.

Thomas Steyer first reported a position in SBRA in Q4 2023 and held it in 10 quarters. The position peaked at $269K in Q1 2026. 461 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Thomas Steyer reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Thomas Steyer sold 14,000 Sabra Healthcare REIT shares in Q2 2026, an estimated $269K.
  • Thomas Steyer first reported a position in Sabra Healthcare REIT in Q4 2023 and held it in 10 quarters.
  • Thomas Steyer's Sabra Healthcare REIT position peaked at $269K in Q1 2026.
  • 461 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.